Abstract: Excessive renal efferent sympathetic nerve activity contributes to hypertension in many circumstances. Although both hemodynamic and tubular effects likely participate, most evidence supports a major role for -adrenergic receptors in mediating the direct epithelial stimulation of sodium retention. Recently, it was reported, however, that norepinephrine activates the thiazide-sensitive NaCl cotransporter (NCC) by stimulating -adrenergic receptors. Here, we confirmed this effect and developed an acute adrenergic stimulation model to study the signaling cascade. The results show that norepinephrine increases the abundance of phosphorylated NCC rapidly (161% increase), an effect largely dependent on -adrenergic receptors. This effect is not mediated by the activation of angiotensin II receptors. We used immunodissected mouse distal convoluted tubule to show that distal convoluted tubule cells are especially enriched for -adrenergic receptors, and that the effects of adrenergic stimulation can occur ex vivo (79% increase), suggesting they are direct. Because the 2 protein kinases, STE20p-related prolineand alanine-rich kinase (encoded by STK39) and oxidative stress-response kinase 1, phosphorylate and activate NCC, we examined their roles in norepinephrine effects. Surprisingly, norepinephrine did not affect STE20p-related proline-and alanine-rich kinase abundance or its localization in the distal convoluted tubule; instead, we observed a striking activation of oxidative stress-response kinase 1. We confirmed that STE20p-related proline-and alanine-rich kinase is not required for NCC activation, using STK39 knockout mice. Together, the data provide strong support for a signaling system involving -receptors in the distal convoluted tubule that activates NCC, at least in part via oxidative stress-response kinase 1. The results have implications about device-and drug-based treatment of hypertension. 
xcessive renal sympathetic nerve activity has been proposed to be a final common pathway for the genesis of hypertension, 1 the largest global contributor to premature death. 2 The sympathetic nervous system seems to be especially important in individuals with an exaggerated response to dietary NaCl (salt-sensitive hypertensives), whether this results from genetic 3 or acquired factors. 4, 5 Norepinephrine infusion in animals reduces urinary sodium excretion and increases blood pressure, [6] [7] [8] but these effects may not reflect direct stimulation of salt reabsorption by renal tubules. Renal nerves also stimulate renin secretion, which increases sodium reabsorption and raises blood pressure via the actions of angiotensin II and aldosterone. Additional effects of the sympathetic nervous system on the renal vasculature may also contribute by altering renal hemodynamics. Where direct stimulation of Na + reabsorption by tubules has been invoked, it is generally accepted that α-adrenergic receptors mediate these effects. 1 More recently, Mu et al 8 reported that chronic adrenergic activation, by norepinephrine or isoproterenol, causes saltsensitive hypertension by activating the thiazide-sensitive NaCl cotransporter (NCC) in the kidney; they postulated that this effect was mediated by glucocorticoid-dependent effects on WNK kinases, specifically serine/threonine-protein WNK4. WNK effects are mediated primarily by the activation of 2 kinases, STE20/SPS1-related proline-and alanine-rich kinase (SPAK; STK39) and oxidative stress-response kinase 1 (OxSR1; OxSR1, often termed OSR1; because OSR1 is the official gene symbol for odd-skipped related 1, we have used the term OxSR1 for clarity). These findings have been controversial, because some aspects were not corroborated by Abstract-Excessive renal efferent sympathetic nerve activity contributes to hypertension in many circumstances. Although both hemodynamic and tubular effects likely participate, most evidence supports a major role for α-adrenergic receptors in mediating the direct epithelial stimulation of sodium retention. Recently, it was reported, however, that norepinephrine activates the thiazide-sensitive NaCl cotransporter (NCC) by stimulating β-adrenergic receptors. Here, we confirmed this effect and developed an acute adrenergic stimulation model to study the signaling cascade. The results show that norepinephrine increases the abundance of phosphorylated NCC rapidly (161% increase), an effect largely dependent on β-adrenergic receptors. This effect is not mediated by the activation of angiotensin II receptors. We used immunodissected mouse distal convoluted tubule to show that distal convoluted tubule cells are especially enriched for β 1 -adrenergic receptors, and that the effects of adrenergic stimulation can occur ex vivo (79% increase), suggesting they are direct. Because the 2 protein kinases, STE20p-related proline-and alanine-rich kinase (encoded by STK39) and oxidative stressresponse kinase 1, phosphorylate and activate NCC, we examined their roles in norepinephrine effects. Surprisingly, norepinephrine did not affect STE20p-related proline-and alanine-rich kinase abundance or its localization in the distal convoluted tubule; instead, we observed a striking activation of oxidative stress-response kinase 1. We confirmed that STE20p-related proline-and alanine-rich kinase is not required for NCC activation, using STK39 knockout mice. Together, the data provide strong support for a signaling system involving β 1 -receptors in the distal convoluted tubule that activates NCC, at least in part via oxidative stress-response kinase 1. 7 and other mediators, such as angiotensin II, were felt likely to have contributed. 9 Interestingly, however, a little-cited study published >30 years ago, using micropuncture techniques, reported that acute isoproterenol infusion stimulated salt transport along the distal convoluted tubule (DCT). 10 Additionally, the work of Morel 11 on adenylyl cyclase activities in microdissected nephron segments showed that the early distal tubule (corresponding to the DCT) of the rat is isoproterenol-responsive. If confirmed, these results would provide novel mechanistic insights linking salt and the adrenergic nervous system that are likely to have therapeutic implications.
During the past 10 years, interest in renal sympathetic control has surged, because technical advances have made renal denervation popular for treating resistant hypertension. 12 Substantial effects of renal nerve ablation on arterial pressure have been observed in many studies, using a variety of experimental models 1 ; early success in clinical trials 13 led to wider adoption of the technique in Europe and high anticipation for Food and Drug Administration approval in the United States. The recent announcement that the large randomized renal denervation trial, SYMPLICITY HTN-3, 14 did not reach its primary efficacy end point, when compared with sham treatment, was disappointing, but it suggests that maximal medical treatment of humans, as achieved in this trial, may interrupt many of the pathways activated by renal nerves.
Although excessive activity of NCC is known to cause hypertension in patients with the Mendelian disease, familial hyperkalemic hypertension (pseudohypoaldosteronism type 2), [15] [16] [17] many investigators suggest that such monogenic syndromes are not relevant for typical hypertension. 18 In common forms of hypertension, however, a role for NCC is suggested by the substantial clinical efficacy of NCC inhibitors, thiazide diuretics, to treat hypertension. In fact, it is often forgotten that these drugs seem to be effective only when hypertension is present; they have little or no effect on arterial pressure in normotensive individuals, but reduce it substantially in hypertensive patients. [19] [20] [21] Therefore, it would be appealing to find a link between sympathetic overactivity and activated NCC. Here, we confirmed that NCC is activated in salt-sensitive hypertension resulting from adrenergic stimulation. Because sympathetic nerve effects are typically rapid, we developed an acute model of adrenergic stimulation, permitting us to study signaling mechanisms in vivo in the absence of chronic compensation. This allowed us to confirm the involvement of β-adrenergic receptors and establish that activation is mediated by an atypical signaling pathway in the DCT.
Methods
See Methods in the online-only Data Supplement.
Results
To confirm the effects of chronic adrenergic stimulation on blood pressure, we infused mice with norepinephrine via osmotic minipump for 2 weeks according to the protocol previously described. 8 Norepinephrine infusion increased systolic blood pressure slightly while mice consumed a normal salt diet (0.49% NaCl); when the mice consumed a high-salt diet (8% NaCl) with continued norepinephrine infusion, however, systolic pressure increased substantially ( Figure 1A) . In vehicle-infused mice, high salt intake did not affect pressure. Norepinephrine also increased the abundance of NCC and phosphorylated (activated) NCC (pNCC; Figure 1B and 1C; Figure S1A and S1B in the online-only Data Supplement). These results are similar to those reported previously by others, 8 although we did not detect changes in the abundance of the NCC regulatory kinase WNK4, at least at the protein level ( Figure 1C ; Figure S1C ).
Although these results confirm that chronic norepinephrine administration increased blood pressure and activated NCC, the effects may not have been direct. To develop an in vivo approach that limits compensatory changes, we determined norepinephrine effects 30 minutes after administration. Indeed, pNCC was increased at this time point; in contrast, and as expected, total NCC abundance remained unchanged (Figure 2A and 2B; Figure S2A -S2E). To determine whether norepinephrine activation of NCC requires angiotensin II, a known NCC activator, 22, 23 angiotensin II receptor type 1a knockout mice were treated with norepinephrine. These animals have normal NCC and pNCC abundance at baseline ( Figure 2C ; Figure S2F and S2G), and the effect on pNCC 30 minutes after norepinephrine treatment was preserved ( Figure 2D ; Figure S2H and S2I).
To test whether α-or β-receptors were responsible for rapid NCC activation, we used the α 1 -specific agonist phenylephrine and the β 1 /β 2 -specific agonist isoproterenol. Stimulation of α 1 -receptors with phenylephrine did not increase pNCC significantly ( Figure 3A ; Figure S3A and S3B), whereas isoproterenol-mediated stimulation of β-receptors did ( Figure 3B ; Figure S3C and S3D). Simultaneous stimulation of α 1 -and β-adrenergic receptors with both phenylephrine and isoproterenol increased pNCC more than either agonist alone, suggesting a potential interaction of receptor subtypes ( Figure 3C ; Figure S3E and S3F). Confirmation that chronic norepinephrine (NE) infusion causes salt-sensitive hypertension and increases NaCl cotransporter (NCC) and phosphorylated NCC (pNCC). A, NE infusion caused salt-induced hypertension. During week 1, all animals were maintained on a normal salt diet without infusion. NE or control infusion (Con) was started during week 2, whereas normal salt diet was continued. During week 3, both groups were switched to a high-salt diet; n=6 per group. at Universitaet Zuerich on November 16, 2014 http://hyper.ahajournals.org/ Downloaded from Although a role for adrenergic receptors in modulating renal renin release is well documented, the role and nature of adrenergic receptors on distal nephron cells is not as clear. We first tested whether DCT cells express β-adrenergic receptors by isolating DCT cells from kidney cortex of mice expressing green fluorescent protein only in the DCT using a fluorescent sorting technique, described previously. 24 RNA isolated from whole kidney and DCT was then used for reverse transcription polymerase chain reaction. Although both β 1 -and β 2 -receptors were detected ( Figure 4A ), β 1 -receptors were highly enriched in DCT cells. In contrast, β 2 -receptors were not, consistent with the results of an unbiased genetic screen of the same cells. 25 When isolated DCT cells were exposed ex vivo to isoproterenol, pNCC increased after 10 minutes ( Figure 4B ).
Mu et al 8 suggested that the WNK kinase pathway is involved in chronic adrenergic effects on NCC. WNKs signal NCC predominantly via SPAK, the major serine/threonine kinase that phosphorylates and activates NCC. To test whether adrenergic agonists activate SPAK, we examined the effects of norepinephrine on SPAK abundance and cellular localization. Norepinephrine administration did not affect SPAK localization within DCT cells and did not increase SPAK abundance, at least within 30 minutes (Figure 5A and 5B; Figure S4A ). It also did not cause an isoform switch, which corresponds to SPAK activation. 26, 27 These results, however, do not indicate whether SPAK is necessary for norepinephrine to stimulate NCC. Thus, we tested the effects of norepinephrine in SPAK −/− mice. Although pNCC abundance at baseline is low in these mice, 26, 27 pNCC increased robustly (Figure 5C and 5D; Figure S4B ). In fact, the proportional increase in pNCC abundance was larger in SPAK −/− mice than in wild-type mice ( Figure S4C) . Because OxSR1 has also been shown to phosphorylate NCC in vitro, 28 and it is expressed along the DCT, we tested whether norepinephrine alters its cellular localization. In both wildtype and SPAK −/− mice, norepinephrine strikingly altered cellular OxSR1 appearance by immunofluorescence ( Figure 6 ). Treatment with norepinephrine caused a striking increase in apical OxSR1, which assumed a ribbon-like appearance near the apical membrane of the DCT. This was especially obvious in the SPAK −/− mice, because OxSR1 assumes a distinctive punctate pattern in SPAK −/− mice, at baseline 26, 27, 29 (Movie S1). Although these results suggested a role for OxSR1 in mediating the effects of norepinephrine, they do not prove that it is essential. To determine whether OxSR1 is essential for increasing the abundance of pNCC, we generated doxycyclineinducible kidney-specific OxSR1 −/− mice. Total-body OxSR1 is embryonic-lethal, so we deleted OxSR1 along the nephron at Universitaet Zuerich on November 16, 2014 http://hyper.ahajournals.org/ Downloaded from using the Pax8 LC1 system ( Figure 7A ; Figure S5A ). After deletion of OxSR1, these mice have normal NCC abundance (both total and phosphorylated; Figure 7B ; Figure S5B and S5C). Thirty minutes after norepinephrine administration, pNCC abundance increased in these mice, but in contrast to the previously performed experiments, the increase was severely blunted ( Figure 7C ; Figure S5D and S5E). This suggests that OxSR1 is essential for the full effect of norepinephrine on NCC.
Discussion
The sympathetic nervous system plays a central role in human blood pressure control. Sympathetic nerves to the kidney contribute importantly to these effects by stimulating renal renin release, modulating renal vascular tone, and activating NaCl transporters. 1 Ablating renal sympathetic nerves is an old approach to resistant hypertension that has recently regained favor, owing to technical advances, which make it easier and safer. In many animal and human studies, this approach has reduced arterial pressure substantially 12 ; yet a rigorous and large clinical trial recently could not confirm that renal denervation is superior to standard care. Thus, although renal denervation reduces blood pressure in models of hypertension, its role in clinical medicine remains to be established.
Here, we confirmed that norepinephrine causes salt-sensitive hypertension in mice, in part, by activating salt reabsorption along the distal nephron via NCC. We show that the effects of norepinephrine on NCC activity occur rapidly and are largely mediated via β-adrenergic receptors; we also identify a novel role for OxSR1 in stimulating NCC in response to stress. Although this inquiry has largely focused on the abundance of pNCC, our immunofluorescence data also suggest that norepinephrine may induce a translocation of NCC from the cytosol to the apical membrane ( Figure 2B ), as reported previously for angiotensin II. 22 In our acute studies, we could not measure salt transport directly, but the abundance of pNCC is used widely as a surrogate for NCC activity. 23, 30 Furthermore, Mu et al 8 reported that thiazide treatment reverses norepinephrineinduced hypertension, supporting a functional role for NCC activity in these effects. The finding that reducing salt intake relowers pressure during continued norepinephrine infusion 8 further supports the importance of salt and is consistent with the effects of salt loading in several other experimental models. 31 The current results clarify the important role that NaCl reabsorption plays in the effects of norepinephrine on arterial pressure and suggest one reason that SYMPLICITY HTN-3 may have failed to achieve its primary goal.
The nature of the direct and indirect effects of adrenergic stimulation on the kidney has been debated for many decades. Here, we show that the effect of norepinephrine to increase pNCC rapidly is fully preserved in mice lacking angiotensin II receptor type 1a, indicating that the effect is not mediated by renin or angiotensin II. The effect seems to be mediated instead through β-adrenergic receptors, as observed previously In place of template cDNA, negative control reactions contained either the product from a cDNA reaction using DCT RNA that lacked reverse transcriptase (−RT) or H 2 O. β 1 AR indicates β 1 -adrenergic receptor; β 2 AR, β 2 -adrenergic receptor; AQP2, aquaporin-2; Con, control; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; and NCC, NaCl cotransporter. B, Ex vivo treatment of fluorescence dissected DCT cells with isoproterenol (Iso) for 10 min increased pNCC-T53 abundance, but did not alter total NCC; n=4 per group. A.U. indicates arbitrary units. Graphs depict mean±SEM; *P<0.05 by unpaired t test.
at Universitaet Zuerich on November 16, 2014 http://hyper.ahajournals.org/ Downloaded from during chronic treatment. 8 Yet, we also detected evidence for synergistic interactions between α-and β-adrenergic receptors to stimulate NCC, a finding compatible with previously contradictory results. Although we find that both β 1 -and β 2 -adrenergic receptor subtypes are expressed in the DCT, β 1 -receptors were highly enriched, suggesting that they play a dominant role. This is consistent with anatomic studies performed in the 1970s and 1980s by Barajas et al. 32, 33 Taken together, our results suggest that NCC can be modulated rapidly by direct β-adrenergic input to DCT cells, probably enhanced by concomitant α-adrenergic stimulation.
Although many groups have observed that norepinephrine infusion increases blood pressure, especially in the setting of dietary NaCl loading, 7, 8 the effects of this treatment on NCC and pNCC abundance, as well as WNK signaling cascade activity, have been more controversial. Our data here confirm that norepinephrine infusion chronically increases both NCC and pNCC and raises arterial pressure, as shown previously by Mu et al. 8 Uchida et al 7 confirmed the blood pressure effects of norepinephrine infusion with dietary salt loading, but could not detect the effects on NCC and WNK4. Although the reasons for these discrepancies are not clear, acute hypertension or dietary salt loading typically downregulates NCC 34, 35 ; thus, the absence of this effect during norepinephrine infusion noted by Uchida et al 7 likely reflects abnormal NCC activation. NCC and the furosemide-sensitive Na-K-2Cl cotransporter are stimulated by a signaling cascade that includes WNK kinases, SPAK and OxSR1. We found no change in WNK4 abundance on norepinephrine stimulation, using an antibody validated against WNK4-knockout tissue, suggesting that WNK4 is not involved. Similarly, we found no apparent effect of norepinephrine on SPAK. SPAK deletion strikingly reduces the abundance of pNCC in vivo, 26, 27, 36, 37 whereas OxSR1 deletion does not. 38 This has led to a simple paradigm in which SPAK, and not OxSR1, was viewed as responsible for activating NCC. 26, 38 Surprisingly, adrenergic stimulation induced a shift in OxSR1 toward the apical membrane of DCT cells, where it might be expected to phosphorylate and activate NCC (Figure 8 ). This apical redistribution occurs whether or not SPAK is present, suggesting that this does not require SPAK/ OxSR1 interactions. Because OxSR1 is capable of phosphorylating cation chloride cotransporters in vitro, 39 this suggests that OxSR1 plays an essential and nonredundant role in the adrenergic response. In confirmation of this, inducing OxSR1 deletion along the nephron, which did not affect basal pNCC abundance, strikingly blunted the ability of norepinephrine to increase pNCC.
A role for OxSR1 in regulating NCC was suggested by Chiga et al, 40 who reported that OxSR1 kinase activity is required for the full familial hyperkalemic hypertension phenotype. They found that disrupting SPAK kinase activity did 
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Luminal Membrane Cartoon shows effects of NE on SPAK (red) and OxSR1 (green) distribution in wild-type mice (left two panels). Note that OxSR1, but not SPAK, shifts to an apical location. The right panels show effects of NE on OxSR1 in SPAK-knockout (KO) mice. Notice that SPAK KO causes OxSR1 to shift to a more punctate appearance. On NE stimulation, OxSR1 shifts substantially toward the apical membrane. NaCl cotransporter (NCC) is phosphorylated (P) on activation. DCT indicates distal convoluted tubule.
at Universitaet Zuerich on November 16, 2014 http://hyper.ahajournals.org/ Downloaded from not completely ameliorate the familial hyperkalemic hypertension phenotype. Instead, the disruption of both OxSR1 and SPAK was necessary to return NCC phosphorylation, blood pressure, and plasma K + back to normal. Grimm et al 27 postulated that OxSR1 requires SPAK to move to the apical membrane, where it can phosphorylate NCC. The current results indicate that this deficiency can be overcome by adrenergic stimulation, because apical OxSR1 is abundant after stimulation in SPAK −/− mice ( Figure 8 ). Taken together, the results suggest complementary, but distinct, roles for SPAK and OxSR1 in regulating NCC. Clearly, SPAK is the dominant NCC-activating kinase under basal conditions, but OxSR1 seems to predominate when the kidney responds to adrenergic stimulation. As suggested by Grimm et al, 27 both kinases may be necessary to activate NCC to its fullest extent.
Guyton 41 suggested that, although the kidney is an especially potent regulator of arterial pressure, these actions are slow. It has been surprising, therefore, to find that NCC is modulated acutely in a variety of circumstances. Acute hypertension, or angiotensin-converting enzyme inhibition, shifts NCC out of the plasma membrane 22, 34, 42 ; acute KCl gavage rapidly reduces pNCC abundance. 43 Here, we have shown that adrenergic stimulation activates NCC rapidly and substantially. This response is most likely a part of the fight-or-flight reflex, described by Cannon, 44 in which the maintenance of arterial pressure and essential organ perfusion provides short-term advantage. When this response is anomalously derived and maintained chronically, however, it likely contributes to pathological hypertension. There has been substantial disappointment that renal denervation did not prove effective in the large rigorous SYMPLICITY HTN-3 trial for the treatment of resistant hypertension.
14 Some commentators have suggested that one difference between the SYMPLICITY HTN-3 trial and earlier trials is the intense focus on appropriate medical management in the SYMPLICITY HTN-3. 45 This focus included aggressive use of thiazide-type diuretics and aldosterone antagonists, both which inhibit NCC. 46 Thus, these drugs may have achieved, medically, some of the effects that nerve ablation would otherwise, rendering the intervention less effective.
Perspectives
The current work shows that adrenergic stimulation of β-receptors in DCT cells stimulates NCC, both acutely and chronically, contributing to salt-sensitive hypertension. This effect is mediated largely by OxSR1, rather than SPAK, identifying an essential and nonredundant role for OxSR1 in modulating NCC activity, a role that was previously unappreciated. The results suggest that renal nerves exert important effects on the kidney by activating salt transport pathways to increase arterial pressure; for this reason, the benefits of invasive procedures may not seem as great, when compared with a control group treated aggressively with drugs that block salt transport.
